AtulKumarSinghalMD

Clinical Trials

• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen Start of enrollment: 2006 Oct 04

  Completed

  Phase 4

• A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) Start of enrollment: 2007 May 15

  Terminated

  Phase 3

• Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis Start of enrollment: 2007 Mar 01

  Completed

  Phase 2

• Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients Start of enrollment: 2008 Nov 01

  Completed

  Phase 2

• A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors Start of enrollment: 2011 Aug 02

  Completed

  Phase 4

• A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis Start of enrollment: 2011 Jul 26

  Completed

  Phase 4

• A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX Start of enrollment: 2013 Nov 07

  Completed

  Phase 3

• Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care Start of enrollment: 2016 Jun 01

  Recruiting

  Not Applicable

• Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment Start of enrollment: 2016 Jul 27

  Completed

  Phase 3

• Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy Start of enrollment: 2016 Aug 08

  Completed

  Phase 3

• Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Start of enrollment: 2016 Aug 30

  Completed

  Phase 3

• A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy Start of enrollment: 2016 Dec 22

  Terminated

  Phase 2

• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis Start of enrollment: 2017 Feb 28

  Active, not recruiting

  Phase 3

• A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE) Start of enrollment: 2018 Nov 26

  Completed

  Phase 1

• Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Start of enrollment: 2019 Apr 01

  Completed

  Phase 2

• A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy Start of enrollment: 2019 May 07

  Completed

  Phase 2

• Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus Start of enrollment: 2019 Mar 26

  Active, not recruiting

  Phase 2

• Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy Start of enrollment: 2019 Dec 03

  Terminated

  Phase 3

• Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy Start of enrollment: 2019 Nov 13

  Terminated

  Phase 3

• Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis Start of enrollment: 2020 Jan 07

  Completed

  Phase 2

• A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis Start of enrollment: 2020 Aug 10

  Active, not recruiting

  Phase 3

• Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA Start of enrollment: 2020 Mar 16

  Completed

  Phase 2

• A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy Start of enrollment: 2020 Aug 18

  Completed

  Phase 3

• ConsideRAte Study - Splenic Stimulation for RA Start of enrollment: 2021 Oct 19

  Recruiting

  Not Applicable

• COVID-19 VaccinE Response in Rheumatology Patients Start of enrollment: 2021 Nov 15

  Recruiting

  Phase 4

• A Study of Baricitinib in Participants With Rheumatoid Arthritis Start of enrollment: 2020 Feb 14

  Recruiting

  Phase 4

• Join now to see all